Cancer Incidence in a Population-Based Cohort of Patients Hospitalized With Diabetes Mellitus in Denmark

Cited by (626)

Items 401–500 of 626

1. Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand.
   Petcharin Srivatanakul, Satoshi Honjo, Pacharin Kittiwatanachot, Adisorn Jedpiyawongse, Thiravud Khuhaprema, Masanao Miwa · 2010 · PubMed
2. Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes
   Belinda Schludi, Abu Saleh Md Moin, Chiara Montemurro, Tatyana Gurlo, Aleksey V. Matveyenko, David Kirakossian, David W. Dawson, Sarah Dry, Peter C. Butler, Alexandra E. Butler · 2017 · JCI Insight
3. CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: A population‐based study in Shanghai, China
   Lifang Hou, Jianfeng Xu, Yu‐Tang Gao, Asif Rashid, Siqun L. Zheng, Lori C. Sakoda, Ming-Chang Shen, Bing‐Sheng Wang, Jie Deng, Tian‐Quan Han et al. · 2005 · International Journal of Cancer
4. Association between Diabetes Mellitus and Hepatocellular Carcinoma: Results of a Hospital- and Community-based Case-control Study
   MICHIYO MATSUO · 2003 · The Kurume Medical Journal
5. Increased Risk of Type 2 Diabetes in Patients With Thyroid Cancer After Thyroidectomy: A Nationwide Cohort Study
   Eun Roh, Eunjin Noh, Soon Young Hwang, Jung A Kim, Eyun Song, Minjeong Park, Kyung Mook Choi, Sei Hyun Baik, Geum Joon Cho, Hye Jin Yoo · 2021 · The Journal of Clinical Endocrinology & Metabolism
6. Diabetes mellitus and risk of brain tumors: A meta-analysis
   JIAO JIAN TONG, HUANG TAO, OUYANG TAO HUI, Jian Chen · 2012 · Experimental and Therapeutic Medicine
7. REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY
   John P. Lynch, David C. Metz, Detlef Schuppan, Yvonne Junker, Donatella Barisani · 2009
8. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
   Zhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, Ben Zhang, Jirong Long, Xiao‐Ou Shu, Marjanka K. Schmidt, Roger Laughlin Milne et al. · 2016 · Cancer Causes & Control
9. Pharmacological Actions of Glucagon-Like Peptide-1, Gastric Inhibitory Polypeptide, and Glucagon
   Revathi Sekar, Kailash Singh, Aloysius Wilfred Raj Arokiaraj, Bkc Chow · 2016 · International review of cytology
10. The association between metabolic syndrome and bladder cancer susceptibility and prognosis: an updated comprehensive evidence synthesis of 95 observational studies involving 97,795,299 subjects
    Xiaofan Peng, Xiangyu Meng, Wei Cheng, Zhenhua Xing, Jiabin Huang, Zhenfei Fang, Xinqun Hu, Qiming Liu, Zhaowei Zhu, Shenghua Zhou · 2018 · Cancer Management and Research
11. Malignancies in patients with insulin-treated diabetes mellitus
    Roland Kath, Ralf Schiel, Ulrich Müller, K. Höffken · 2000 · Journal of Cancer Research and Clinical Oncology
12. Risk of bladder cancer in patients with diabetes: a retrospective cohort study
    Maria E. Goossens, Maurice Petrus Zeegers, Marloes T. Bazelier, Marie L. De Bruin, Frank Buntinx, Frank de Vries · 2015 · BMJ Open
13. Diabetes and Risks of Right-Sided and Left-Sided Colon Cancer: A Meta-Analysis of Prospective Cohorts
    Wenxuan Xiao, Jinglong Huang, Chuanyi Zhao, Lu Ding, Xuan Wang, Bian Wu · 2022 · Frontiers in Oncology
14. Prognostic Significance of Diabetes Mellitus in Localized Renal Cell Carcinoma
    Sang‐Cheol Lee, Sung Kyu Hong, Cheol Hun Kwak, H. H. Kim, S. E. Lee · 2012 · Japanese Journal of Clinical Oncology
15. Diabetes in midlife and risk of cancer in late life: A nationwide Swedish twin study
    Cuiping Bao, Nancy L. Pedersen, Rongrong Yang, Anna Marseglia, Weige Xu, Yaogang Wang, Xiuying Qi, Weili Xu · 2018 · International Journal of Cancer
16. Pancreatic Cancer: A Review of Risk Factors
    Raluca Roxana Grigorescu, Ioana Alexandra Husar-Sburlan, Cristian Gheorghe · 2024 · Life
17. The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia
    Hung‐Yang Kuo, Zhong‐Zhe Lin, Raymond Nien-Chen Kuo, Wen‐Yi Shau, Chiu-Lin Lai, Yen‐Yun Yang, Yu‐Yun Shao, Chiun Hsu, Wen-Fan Cheng, Ann‐Lii Cheng et al. · 2015 · The Oncologist
18. Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease‐hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective
    Delia D’Avola, Ismaïl Labgaa, Augusto Villanueva · 2016 · Clinical Liver Disease
19. Diabetes and risk of esophageal and gastric adenocarcinomas
    Xuejuan Jiang, Leslie Bernstein, Chiu‐Chen Tseng, Anna H. Wu · 2011 · International Journal of Cancer
20. Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study
    Massimo Giusti, Lorenzo Mortara, Roberta Degrandi, Francesca Cecoli, Michele Mussap, Guido Rodriguez, Diego Ferone, Francesco M. Minuto · 2008 · Thyroid Research
21. Gene 33 inhibits apoptosis of breast cancer cells and increases poly(ADP-ribose) polymerase expression
    Jie Xu, Adam B. Keeton, Liyu Wu, J. Lee Franklin, Xu Cao, Joseph L. Messina · 2005 · Breast Cancer Research and Treatment
22. Alcoholic beverages and risk of renal cell cancer
    Jacoba P. Greving, Jung Eun Lee, Alicja Wolk, C Lukkien, Per Lindblad, Anna Bergström · 2007 · British Journal of Cancer
23. Cost-Effectiveness of Treatment of Early Stage Endometrial Cancer
    Heidi W Ashih, Tara Gustilo-Ashby, Evan R. Myers, Jeffrey Campbell Andrews, Daniel L. Clarke‐Pearson, Donald A. Berry, Andrew Berchuck · 1999 · Gynecologic Oncology
24. The association between type 1 and 2 diabetes mellitus and the risk of leukemia: a systematic review and meta-analysis of 18 cohort studies
    Pengfei Yan, Yongbo Wang, Tao Fu, Yu Liu, Zhi-Jiang Zhang · 2020 · Endocrine Journal
25. Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies
    Hao Liu, Yong Zhang, Min Ai, Jun Wang, Bo Jin, Zhaowei Teng, Yansheng Wang, Li Li · 2016 · Medical science monitor basic research/Medical science monitor. Basic research
26. Burden of diabetes and oral cancer in India
    Rajendra Prabhu Abhinav, Joanne W. Williams, Patricia M. Livingston, Ranjit Mohan Anjana, Viswanathan Mohan · 2020 · Journal of Diabetes and its Complications
27. Diabetes and Hepatocellular Carcinoma: What Role Does Diabetes Have in the Presence of Other Known Risk Factors?
    Jessica A. Davila · 2010 · The American Journal of Gastroenterology
28. Type 2 diabetes mellitus and risk of head and neck cancer subtypes: a systematic review and meta-analysis of observational studies
    Pengfei Yan, Yongbo Wang, Xue Min Yu, Yu Liu, Zhi-Jiang Zhang · 2021 · Acta Diabetologica
29. Does Chronic Obstructive Pulmonary Disease with or without Type 2 Diabetes Mellitus Influence the Risk of Lung Cancer? Result from a Population-Based Cohort Study
    Te‐Chun Shen, Wei‐Sheng Chung, Cheng‐Li Lin, Chang‐Ching Wei, Chia‐Hung Chen, Hung-Jen Chen, Chih‐Yen Tu, Te‐Chun Hsia, Chuen‐Ming Shih, Wu‐Huei Hsu et al. · 2014 · PLoS ONE
30. Diabetes and risk of tumors: oncologic considerations
    András Rosta · 2011 · Orvosi Hetilap
31. Incidence of cancer in a population-based cohort of patients with type 2 diabetes
    Marianne Ulcickas Yood, Susan A. Oliveria, Ulka B. Campbell, Carol E. Koro · 2008 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
32. Bicluster and Pathway Enrichment Analysis of HCV-induced Cirrhosis and Hepatocellular Carcinoma
    Peng Cheng, You Cheng, Mei X. Su, Dong Li, Guo Zhen Zhao, Hui Jiang Gao, Yan Li, Jie Y. Zhu, Hua Li, Tao Zhang · 2012 · Asian Pacific Journal of Cancer Prevention
33. Obesity and Pancreatic Cancer
    Dominique S. Michaud · 2016 · Recent results in cancer research/Recent Results in Cancer Research
34. Diabetes Mellitus as a Risk Factor for High Grade Renal Cell Carcinoma
    Alper Ötünçtemur, Emin Özbek, Süleyman Şahin, Murat Dursun, Hüseyin Beşiroğlu, İsmail Köklü, Mustafa Erkoç, Eyyüp Danış, Muammer Bozkurt, Ahmet Gurbuz · 2014 · Asian Pacific Journal of Cancer Prevention
35. 1α, 25-Dihydroxyvitamin D3 inhibits hepatic chromosomal aberrations, DNA strand breaks and specific DNA adducts during rat hepatocarcinogenesis
    B.K. Saha, Anupam Bishayee, N.B. Kanjilal, Madhumita Chatterjee · 2001 · Cellular and Molecular Life Sciences
36. Venous thromboembolism and risk of cancer in patients with diabetes mellitus
    Diana Hedevang Christensen, Erzsébet Horváth–Puhó, Reimar Wernich Thomsen, Søren Tang Knudsen, Olaf M. Dekkers, Paolo Prandoni, Henrik Toft Sørensen · 2016 · Journal of Diabetes and its Complications
37. Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics
    Yuanqing Yan, Ruli Gao, Thao Le Phuong Trinh, Maria B. Grant · 2017 · Clinical Cancer Research
38. Association of Selected Medical Conditions With Breast Cancer Risk in Korea
    Sun Jae Jung, Minkyo Song, Ji‐Yeob Choi, Nan Song, Sue K. Park, Keun‐Young Yoo, Daehee Kang · 2013 · Journal of Preventive Medicine and Public Health
39. Cancer incidence and mortality in 23 000 patients with type 1 diabetes in the UK: Long‐term follow‐up
    Anthony J. Swerdlow, Michael Emlyn Jones, Stefan D. Slater, Andrew C Burden, Johannes L. Botha, Norman R Waugh, Andrew D. Morris, Wendy Gatling, Kathleen M. Gillespie, Christopher Patterson et al. · 2023 · International Journal of Cancer
40. Promotion and selection by serum growth factors drive field cancerization, which is anticipated in vivo by type 2 diabetes and obesity
    Harry Rubin · 2013 · Proceedings of the National Academy of Sciences
41. The effect of metabolic syndrome on head and neck cancer incidence risk: a population-based prospective cohort study
    Huaili Jiang, Lei Zhou, Qiangsheng He, Kanglun Jiang, Jinqiu Yuan, Xinsheng Huang · 2021 · Cancer & Metabolism
42. S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL
    Thomas Theodor Werner Seufferlein, Julia V. Mayerle, Stefan Böck, Thomas Baptist Brunner, Thomas Jens Ettrich, Lars Grenacher, Thomas Mathias Gress, Thilo Hackert, Volker Heinemann, Angelika M. R. Kestler et al. · 2022 · Zeitschrift für Gastroenterologie
43. Diabetes, colorectal cancer and cyclooxygenase 2 inhibition
    Camilla Smith, G McKay, Miles Fisher · 2008 · International Journal of Clinical Practice
44. Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
    Amra Jujić, Christopher Godina, Mattias Belting, Olle Melander, Jens Juul Holst, Emma Ahlqvist, Maria F. Gomez, Peter M. Nilsson, Helena Jernström, Martin Magnusson · 2023 · Scientific Reports
45. Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer
    Yevgeniya S. Kushchayeva, Sergiy V. Kushchayev, Kirk Ernest Jensen, Rebecca J. Brown · 2022 · Cancers
46. Drinking Water Disinfection By‐Products
    Richard J. Bull · 2008 · Wiley eBooks
47. Primary Neoplasms of the Liver
    Junichi Shindoh, Kristoffer Watten Brudvik, Jean‐Nicolas Vauthey · 2017 · Holland‐Frei Cancer Medicine
48. Risk of Colorectal Cancer in Type 2 Diabetic Patients: A Population-based Cohort Study
    Jen‐Yu Wang, Ting‐Ting Chao, Chih‐Cheng Lai, Cheng-Yi Wang, Vin‐Cent Wu, So-Mon Wang, Hen-I Lin, Sai‐Hung Tang, Hui‐Wen Lin · 2013 · Japanese Journal of Clinical Oncology
49. Risk Factors for Renal Cell Cancer in a Japanese Population
    Masakazu Washio, Mitsuru Mori · 2009 · Clinical medicine Oncology
50. Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
    Mario Umberto Mondelli, Bruno, Savojardo, Piero Luigi Almasio · 2011 · Hepatic Medicine Evidence and Research
51. Brain energy metabolism parameters in an animal model of diabetes
    Luciane Bisognin Ceretta, Gislaine Z. Réus, Gislaine Tezza Rezin, Giselli Scaini, Emilio Luiz STRECK, João Quevedo · 2010 · Metabolic Brain Disease
52. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma
    Lorenz Kuske, Armand Mensen, Beat Müllhaupt, Francesco Negro, David Semela, Darius Moradpour, PJ Malé, Markus Hermann Heim, Raffaele Malinverni, Andreas Cerny et al. · 2012 · Swiss Medical Weekly
53. Effect of Type 2 Diabetes Mellitus on Prognosis of Nonmetastatic Renal Cell Cancer
    Evren Süer, Erdem Öztürk, Ömer Gülpınar, Aytaç Kayış, Sümer Baltacı · 2013 · Korean journal of urology
54. Role of the Wnt signalling pathway in the development of endothelial disorders in response to hyperglycaemia
    Martyna Durak-Kozica, Elżbieta Paszek, Ewa Łucja Stępień · 2019 · Expert Reviews in Molecular Medicine
55. Treat liver to beat diabetes
    Shivani M. Desai, Avinash Purushottam Sanap, Ramesh Ramchandra Bhonde · 2020 · Medical Hypotheses
56. Inverse relationship between insulin receptor expression and progression in renal cell carcinoma
    Makoto Takahashi, Takamitsu Inoue, Mingguo Huang, Kazuyuki Numakura, Hiroshi Tsuruta, Mitsuru Saito, Atsushi Maeno, Eijiro Nakamura, Shintaro Narita, Norihiko Tsuchiya et al. · 2017 · Oncology Reports
57. Multivariate Analysis on the Effects of Diabetes and related Clinical Parameters on Cervical Cancer Survival Probability
    Syed Wasif Gillani, Hisham A. Zaghloul, Irfan Altaf Ansari, Mohi Iqbal Mohammad Abdul, Syed Azhar Syed Sulaiman, Mirza Rafi Baig, Hassaan Anwer Rathore · 2019 · Scientific Reports
58. Modifiers of Liver-Related Manifestation in the Course of NAFLD
    Patrik Nasr, Julia Blomdahl, Stergios Kechagias, Mattias Ekstedt · 2020 · Current Pharmaceutical Design
59. Premalignant conditions of the pancreas
    Pauline de la Μ. Hall, Robb E. Wilentz, Willouw De Klerk, Philippus P.C. Bornman · 2002 · Pathology
60. Diabetes and the Gastrointestinal Tract
    Zeeshan Ramzan, Henry P. Parkman · 2010 · Diabetes
61. Association between diabetes or antidiabetic therapy and lung cancer: A meta‐analysis
    Zhida Wang, Cuiping Bao, Cheng Su, Weili Xu, Hongbin Luo, Liming Chen, Xiuying Qi · 2013 · Journal of Diabetes Investigation
62. Diabetes Mellitus Reduces Prostate Cancer Risk - No Function of Age at Diagnosis or Duration of Disease
    Hua Xu, Shan-Hua Mao, Guanxiong Ding, Qiang Ding, Haowen Jiang · 2013 · Asian Pacific Journal of Cancer Prevention
63. Impact of metformin on serum prostate-specific antigen levels
    Jee Soo Park, Kwang Suk Lee, Won Sik Ham, Byung Ha Chung, Kyo Chul Koo · 2017 · Medicine
64. The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
    Emily J. Gallagher, Ruslan Novosyadlyy, Shoshana Yakar, Derek LeRoith · 2009 · Springer eBooks
65. Contribution of obesity to pancreatic carcinogenesis
    Andrew A. Gumbs, Marc Bessler, Luca Milone, Beth Schrope, John A. Chabot · 2008 · Surgery for Obesity and Related Diseases
66. Hard clinical outcomes in patients with NAFLD
    Ramesh K. Kumar · 2013 · Hepatology International
67. Increased cancer mortality in type 2 diabetes (ZODIAC-3).
    Gijs W.D. Landman, Lielith J. Ubink-Veltmaat, Nanne Kleefstra, Boudewijn J. Kollen, Henk J. G. Bilo · 2008 · PubMed
68. Past Medical History and Risk of Death due to Hepatocellular Carcinoma, Univariate Analysis of JACC Study Data
    Akira Shibata, Itsuro Ogimoto, Youichi Kurozawa, TAKAYUKI NOSE, Takesumi Yoshimura, Hiroshi Suzuki, Nobuo Iwai, Ritsu Sakata, Yuki Fujita, SHOKO ICHIKAWA et al. · 2003 · The Kurume Medical Journal
69. Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin
    Marica Meroni, Miriam Longo, Paola Dongiovanni · 2024 · Frontiers in Endocrinology
70. The Potential Interplay of Adipokines with Toll-Like Receptors in the Development of Hepatocellular Carcinoma
    Shen‐Nien Wang, Sen‐Te Wang, King Teh Lee · 2011 · Gastroenterology Research and Practice
71. Diabetes Mellitus in Pancreatic Cancer Patients in the Czech Republic: Sex Differences
    Jan Trna, Petr Dítě, Arona Adamcová, Brianna J. Crawford, Markéta Hermanová · 2012 · Experimental Diabetes Research
72. Incidence and epidemiological features of cancers of the genitourinary tract in Izmir between 1993-2002.
    Sultan Eser, Ferruh Zorlu, Rauf Taner Divtik, Çağ Çal, Mehmet Şahin Özkan, Ziya Kırkalı · 2009 · PubMed
73. Risk of Malignant Neoplasms of Kidney and Bladder in a Cohort Study of the Diabetic Population in Taiwan With Age, Sex, and Geographic Area Stratifications
    Hua-Fen Chen, Shwe-Winn Chen, Ya‐Hui Chang, Chung‐Yi Li · 2015 · Medicine
74. Logistic regression prediction model identify type 2 diabetes mellitus as a prognostic factor for human papillomavirus-16 associated head and neck squamous cell carcinoma
    Aastha Sobti, Fatemeh Saheb Sharif‐Askari, Saif Khan, Narjes Saheb Sharif‐Askari, Mahmood Yaseen Hachim, Luke Williams, Yuanping Zhou, Colin Hopper, Rifat Hamoudi · 2019 · PLoS ONE
75. Diabetes History and Gastric Cancer Risk: Different Results by Types of Follow-Up Studies
    Jong‐Myon Bae · 2022 · Asian Pacific Journal of Cancer Prevention
76. Diabetes Mellitus Is Associated With the Presence of Metastatic Spread at Disease Presentation in Hepatocellular Carcinoma
    Gregory Clayton Connolly, Saman Safadjou, Rui Chen, Afamefuna M. Nduaguba, Richard Francis Dunne, Alok A. Khorana, Aram F. Hezel · 2012 · Cancer Investigation
77. Does diabetes decrease the risk of glioma? A systematic review and meta-analysis of observational studies
    Yongbo Wang, Yi Sun, Juan Tang, Wei Zhou, Xiaoxue Liu, Yongyi Bi, Zhi-Jiang Zhang · 2018 · Annals of Epidemiology
78. Chapter 2: Diagnosis and surveillance
    2010 · Hepatology Research
79. Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma
    Gregory Clayton Connolly, Saman Safadjou, Randeep Kashyap, Rui Chen, Mark S. Orloff, Aram F. Hezel · 2013 · BMC Gastroenterology
80. Dominant Negative α-Subunit of FTase Inhibits Effects of Insulin and IGF-I in MCF-7 Cells
    Curtis Scott Solomon, Marc Lee Goalstone · 2002 · Biochemical and Biophysical Research Communications
81. Epidemiology of Pancreatic Cancer
    Aravind Sugumar, Santhi Swaroop Vege · 2014
82. Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database
    Bora Park, Hakmo Lee, Suyeon Park, Eun Sil Lee, Jeong Jae Lee, Young Lee, Je Hyun Seo · 2022 · BMC Women s Health
83. New-Onset Diabetes After Renal Transplantation (NODAT): Is It a Risk Factor for Renal Cell Carcinoma or Renal Failure?
    Hai-bo Nie, Wei Wang, Yongbin Zhao, Xiaoming Zhang, Yuansong Xiao, Qinsong Zeng, Changzhen Zhang, Lei Zhang · 2019 · Annals of Transplantation
84. Age- and Sex-Specific Risks of Colorectal Cancers in Diabetic Patients
    Hua-Fen Chen, Peter Chen, Ying-Hwa Su, Hui-Fang Su, Chung‐Yi Li · 2012 · The Tohoku Journal of Experimental Medicine
85. Impact of diabetes on cancer chemotherapy outcome: A retrospective analysis
    V.S.S. Attili, PP Bapsy, HemantK Dadhich, Ullas Batra, D. Lokanatha, K. Govind Babu · 2007 · International Journal of Diabetes in Developing Countries
86. Investigation of the association between metabolic syndrome and breast cancer patients
    Delaram Eskandari, Niloofar Khodabandehloo, Abbas Gholami, Hosein Samadanifard, Alireza Hejrati · 2020 · European Journal of Translational Myology
87. The association between paternal prostate cancer and type 2 diabetes
    Peter Meyer, Christine S. Zuern, Norbert Hermanns, Thomas Haak · 2007 · Journal of Carcinogenesis
88. Diabetes is associated with increased liver cancer incidence and mortality in adults: A report from Asia Cohort Consortium
    Nhan Thi Ho, Sarah Krull Abe, Md. Shafiur Rahman, Md. Rashedul Islam, Eiko Saito, Prakash Chandra Gupta, Mangesh Suryakant Pednekar, Norie Sawada, Shoichiro Tsugane, Akiko Tamakoshi et al. · 2024 · International Journal of Cancer
89. Resection of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma: A Western Experience
    Brian Shrager, Ghalib A. Jibara, Parissa Tabrizian, Sasan Roayaie, Stephen C. Ward · 2012 · International Journal of Surgical Oncology
90. Diabetes: One of Few Remarkable Differences in Clinicopathologic Features Between Cirrhotic and Noncirrhotic Swedes With Hepatocellular Carcinoma
    Jerzy Kaczynski, Göran K. Hansson, Sven Wallerstedt · 2006 · Digestive Diseases and Sciences
91. Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma
    Naota Taura, Tatsuki Ichikawa, Hisamitsu Miyaaki, Hiroshi Yatsuhashi, Hiromi Ishibashi, Kazuhiko Nakao · 2010 · Experimental and Therapeutic Medicine
92. Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community
    Kuo‐Chin Chang, Pei‐Shan Tsai, Mei‐Chin Hsu, Shu-Fen Hung, Chin‐Chen Tsai, Sheng‐Nan Lu · 2010 · Journal of Gastroenterology
93. Association of Metabolic Syndrome with the Risk of Head and Neck Cancer: A 10-Year Follow-Up Study of 10 Million Initially Healthy Individuals
    Geun‐Jeon Kim, Kyung-Do Han, Young‐Hoon Joo · 2023 · Cancers
94. La diabetes en la cirrosis hepática
    Diego García‐Compeán, Joel Omar Jáquez-Quintana, José Alberto González, Fernando Javier Lavalle-Gonzalez, Jesús Zacarías Villarreal‐Pérez, Héctor Jesús Maldonado-Garza · 2013 · Gastroenterología y Hepatología
95. Psoriatic patients with diabetes are prone to develop digestive organ cancers: A population-based study in Taiwan
    Cheng-Che Eric Lan, Ying‐Chin Ko, Hsin‐Su Yu, Wan-Chen Li, Ching‐Shuang Wu, Yiwei Lu, Yi‐Hsin Yang, Gwo‐Shing Chen · 2012 · Journal of Dermatological Science
96. Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study
    Dong‐Hoe Koo, Kyungdo Han, Hong Joo Kim, Cheol‐Young Park · 2019 · Acta Diabetologica
97. Sugar pills for pancreatic cancer: The benefits of becoming (insulin) sensitive
    Anna Mae Diehl · 2001 · Gastroenterology
98. Epidemiology of the Hepatocellular Carcinoma
    Angelo Sangiovanni, Massimo Colombo · 2009 · CRC Press eBooks
99. Endometrial Cancer
    Linda S. Cook, Noel S. Weiss · 2000 · Elsevier eBooks
100. Is type 2 diabetes a risk factor for pancreatic cancer?
     Raffaele Pezzilli, Riccardo Casadei, Antonio Maria Morselli‐Labate · 2009 · PubMed